biological source
mouse
conjugate
unconjugated
antibody form
IgG fraction of antiserum
antibody product type
primary antibodies
clone
polyclonal
form
buffered aqueous solution
species reactivity
human
technique(s)
western blot: 1 μg/mL
UniProt accession no.
shipped in
dry ice
storage temp.
−20°C
target post-translational modification
unmodified
Gene Information
human ... NAT9(26151)
Immunogen
NAT9 (NP_056469.2, 1 a.a. ~ 207 a.a) full-length human protein.
Sequence
MRLNQNTLLLGKKVVLVPYTSEHVPSRYHEWMKSEELQRLTASEPLTLEQEYAMQCSWQEDADKCTFIVLDAEKWQAQPGATEESCMVGDVNLFLTDLEDLTLGEIEVMIAEPSCRGKGLGTEAVLAMLSYGVTTLGLTKFEAKIGQGNEPSIRMFQKLHFEQVATSSVFQEVTLRLTVSESEHQWLLEQTSHVEEKPYRDGSAEPC
Sequence
MRLNQNTLLLGKKVVLVPYTSEHVPSRYHEWMKSEELQRLTASEPLTLEQEYAMQCSWQEDADKCTFIVLDAEKWQAQPGATEESCMVGDVNLFLTDLEDLTLGEIEVMIAEPSCRGKGLGTEAVLAMLSYGVTTLGLTKFEAKIGQGNEPSIRMFQKLHFEQVATSSVFQEVTLRLTVSESEHQWLLEQTSHVEEKPYRDGSAEPC
Biochem/physiol Actions
NAT9 (N-acetyltransferase 9) is a member of the N-acetyltransferase family mapped on chromosome 17q25. It has been reported that NAT9 gene may be associate with inflammatory arthritis, referred to as psoriatic arthritis (PsA). Single-nucleotide polymorphisms (SNPs) in NAT9 have been linked to a chronic inflammatory skin disorder, Psoriasis. It has also been reported that RUNX1-mediated defective regulation of NAT9 leads to a susceptible factor responsible for psoriasis.
Physical form
Solution in phosphate buffered saline, pH 7.4
Still not finding the right product?
试用我们的 产品选型工具 工具缩小选择范围
存储类别
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable